159 related articles for article (PubMed ID: 8527701)
1. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
Fock KM; Kang JY; Ng HS; Ng TM; Gwee KA; Lim CC
J Gastroenterol Hepatol; 1995; 10(4):379-82. PubMed ID: 8527701
[TBL] [Abstract][Full Text] [Related]
2. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
3. Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer: a randomized, double-masked, multicenter study.
Zuberi SJ; Khan AQ; Irshad-ul-Haque I; Hussain A; Hasnain SS; Shah S; Sadick A; Yusuf MZ; Reuter M
Clin Ther; 1996; 18(6):1207-12. PubMed ID: 9001837
[TBL] [Abstract][Full Text] [Related]
4. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
Hüttemann W
Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group.
Brandstätter G; Marks IN; Lanza F; Kogut D; Cobert B; Savitsky JP; Bender W; Labs R; Wurzer H
Clin Ther; 1995; 17(3):467-78. PubMed ID: 7585851
[TBL] [Abstract][Full Text] [Related]
6. A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.
Walt RP; Logan RF; Hawkey CJ; Daneshmend TK; Long RG; Cooper BT; Langman MJ; Collins M; Street R
Aliment Pharmacol Ther; 1991 Jun; 5(3):301-7. PubMed ID: 1679668
[TBL] [Abstract][Full Text] [Related]
7. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
8. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
9. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.
Judmaier G
Drugs; 1988; 35 Suppl 3():120-6. PubMed ID: 2905240
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
12. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
Hentschel E; Schütze K
Drugs; 1988; 35 Suppl 3():96-101. PubMed ID: 2905256
[TBL] [Abstract][Full Text] [Related]
13. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Amarapurkar DN; Parikh SS; Desai HG
J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine in the treatment of duodenal ulceration.
Peden NR; Boyd EJ; Saunders JH; Wormsley KG
Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471
[TBL] [Abstract][Full Text] [Related]
16. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
[TBL] [Abstract][Full Text] [Related]
17. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
Meneghelli UG; Zaterka S; de Paula Castro L; Malafaia O; Lyra LG
Am J Gastroenterol; 2000 Jan; 95(1):62-6. PubMed ID: 10638560
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
19. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
Inoue M
Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
